Targeting FHL2 for EGFRvIII-positive glioblastoma.
Targeting FHL2 for EGFRvIII-positive glioblastoma.
Oncotarget. 2018 Dec 04;9(95):36730-36731
Authors: Sun L, Lan Q, Li M
PMID: 30613360 [PubMed]
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research
More News: